1589818-98-3

Basic information

• Product Name: 4-(2-methylthiazol-4-yl)-N-(3,3,3-trifluoropropyl)benzamide
• Synonyms: 4-(2-methylthiazol-4-yl)-N-(3,3,3-trifluoropropyl)benzamide
• CAS NO: 1589818-98-3
• Molecular Weight: 314.331
• Mol File: 1589818-98-3.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: 4-(2-methylthiazol-4-yl)-N-(3,3,3-trifluoropropyl)benzamide(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(2-methylthiazol-4-yl)-N-(3,3,3-trifluoropropyl)benzamide(1589818-98-3)
• EPA Substance Registry System: 4-(2-methylthiazol-4-yl)-N-(3,3,3-trifluoropropyl)benzamide(1589818-98-3)

Safety Data

• Hazardous Substances Data: 1589818-98-3(Hazardous Substances Data)

Upstream product

• 294620-60-3 4-(2-methylthiazol-4-yl)benzoic acid 
• 2968-33-4 (3,3,3-trifluoropropyl)amine hydrochloride 

Relevant articles and documents

COMPOUNDS FOR USE IN THE TREATMENT OF MYCOBACTERIAL INFECTIONS

The present invention concerns compounds of general formula (I): in which Y and Z are chosen from CH and N; T is chosen from CO or SO2; n is 1 to 3; R1 represents a group chosen, for example, from C1-C3 alkyl chains unsubstituted or substituted by fluorine, the unsubstituted or substituted cyclic, cyano, azido, alkoxy and phenyl groups; and R is chosen from the azido, cyano, alkinyl and 2-benzothiazolyl groups and an optionally substituted aromatic heterocycle with five vertices; and the use thereof in the treatment of bacterial and mycobacterial infections such as, for example, tuberculosis, leprosy and atypical mycobacterial infections. The present invention also concerns pharmaceutical compositions comprising, as the active ingredient, at least one of the abovementioned compounds and optionally an antibiotic activatable via the EthA pathway